当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Breast Cancer Stem Cell Adaptability and Heterogeneity Regulated by Novel Molecular Regulators

Rui Tu

Breast cancer is a complex and heterogeneous disease characterized by the presence of breast cancer stem cells (BCSCs). These BCSCs exhibit unique properties, including self-renewal, tumorigenicity, and resistance to therapy, which contribute significantly to disease progression and treatment challenges. Understanding the mechanisms governing BCSC adaptability and heterogeneity is crucial for the development of more effective breast cancer treatments. Recent research has revealed novel molecular regulators that play pivotal roles in these aspects of BCSC behavior. This abstract explores the concept of BCSCs and their role in breast cancer, discusses the adaptability and heterogeneity of BCSCs, and highlights emerging molecular regulators that offer promising avenues for therapeutic intervention. Targeting these regulators represents a potential breakthrough in breast cancer treatment, offering hope for improved outcomes for patients with this devastating disease.